Although its therapeutic effect was already demonstrated in an HD animal model [55], in our cell model, BBR did not show significant effects on the clearance of the mutant HTT, both at levels of the SDS-soluble species (evaluated in WB, Figure 4E) and of the high-molecular-weight aggregated species (evaluated in FRA, Figure 4F). This evidence concerns the gene HTT and Huntington disease.